VITURA HEALTH LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.115 AUD | +9.52% |
|
-28.12% | -54.90% |
| 04-26 | Vitura Health's Shares Jump 19% After Securing Injunction Order Over Code4 Spat | MT |
| 04-24 | Vitura Health's Services Agreement with Code4 at Risk of Termination; Shares Plunge 31% | MT |
| Sales 2022 | 66.99M 43.76M 3.5B | Sales 2023 | 117M 76.65M 6.14B | Capitalization | 287M 187M 14.99B |
|---|---|---|---|---|---|
| Net income 2022 | 6M 3.92M 314M | Net income 2023 | 13M 8.49M 680M | EV / Sales 2022 | 1.89 x |
| Net cash position 2022 | 11.02M 7.2M 576M | Net cash position 2023 | 17.57M 11.48M 919M | EV / Sales 2023 | 2.29 x |
| P/E ratio 2022 |
20.2
x | P/E ratio 2023 |
21.3
x | Employees | - |
| Yield 2022 |
4% | Yield 2023 |
1.94% | Free-Float | 25.01% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +9.52% | ||
| 1 week | -28.12% | ||
| Current month | -39.47% | ||
| 1 month | -37.84% | ||
| 3 months | -53.06% | ||
| 6 months | -66.67% | ||
| Current year | -54.90% |
1 week
0.09
0.16
1 month
0.090.19
Current year
0.090.29
1 year
0.090.60
3 years
0.091.04
5 years
0.071.04
10 years
0.071.04
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 02/12/18 | |
Kirsty Garrett
COO | Chief Operating Officer | - | 30/09/23 |
Guy Headley
BRD | Director/Board Member | - | 15/12/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Robert Iervasi
CHM | Chairman | - | 02-12 |
Guy Headley
BRD | Director/Board Member | - | 15/12/21 |
Marcia Walker
BRD | Director/Board Member | - | 15/12/21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 0.115 | +9.52% | 1,131,214 |
| 24/04/24 | 0.105 | -4.55% | 1,111,101 |
| 23/04/24 | 0.11 | -31.25% | 12,613,460 |
| 19/04/24 | 0.16 | -5.88% | 35,346 |
| 18/04/24 | 0.17 | 0.00% | 79,348 |
Delayed Quote Australian S.E., April 26, 2024 at 07:10 am
More quotes
Vitura Health Limited is a diversified digital health company that operates various businesses via its subsidiaries CanView, Doctors on Demand, Cortexa, CDA Clinics, Cannadoc, BHC and Adaya. It consists of Medical segment involving the sale and distribution of medicinal cannabis products; Clinics segment involving the operation of medicinal cannabis clinics, and Consumer segment involving the sale of consumer (non-medical) products in both Australia and Asia. Burleigh Heads Cannabis operates the prescriber, patient, pharmacy and supplier online platform, CanView, which sells and distributes 350+ therapeutic products and device stock-keeping units (SKUs) within Australia from medicinal cannabis producers. It also owns Doctors on Demand Pty Ltd, a telehealth platform business that provides primary health solutions. It owns 75.5% Cannadoc Health Pty Ltd, a medicinal cannabis clinic business that undertakes telehealth consultations with patients seeking access to medicinal cannabis.
Sector
Pharmaceuticals
Calendar
27/08/2024
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -54.90% | 43.19M | |
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| +0.09% | 1.65B | |
| -7.89% | 1.68B | |
| -12.97% | 1.53B | |
| +33.40% | 1.38B |
- Stock Market
- Equities
- VIT Stock
